Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven O Marx

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
The Journal of Clinical Investigation|January 16, 2024
A membrane-associated phosphoswitch in Rad controls adrenergic regulation of cardiac calcium channelsArianne Papa, Pedro J Del Rivero Morfin, Bi-Xing Chen, et al.
Circulation Research|October 22, 2020
Adrenergic Ca<sub>V</sub>1.2 Activation via Rad Phosphorylation Converges at α<sub>1C</sub> I-II LoopArianne Papa, Jared Kushner, Jessica A Hennessey, et al.
Cell Reports. Medicine|March 15, 2023
Engineered cardiac tissue model of restrictive cardiomyopathy for drug discoveryBryan Z Wang, Trevor R Nash, Xiaokan Zhang, et al.
JCI Insight|October 28, 2021
Attenuating persistent sodium current-induced atrial myopathy and fibrillation by preventing mitochondrial oxidative stressUma Mahesh R Avula, Haikel Dridi, Bi-Xing Chen, et al.
Nature Communications|October 17, 2024
Multiple beta cell-independent mechanisms drive hypoglycemia in Timothy syndromeMaiko Matsui, Lauren E Lynch, Isabella Distefano, et al.
Nature Cardiovascular Research|November 25, 2022
Rad regulation of Ca<sub>V</sub>1.2 channels controls cardiac fight-or-flight responseArianne Papa, Sergey I Zakharov, Alexander N Katchman, et al.
American Heart Journal|January 31, 2025
Characterizing high-risk enrollment criteria and impact on clinical outcomes in a large randomized clinical trial: Insights from the TWILIGHT trialPhilippe Gabriel Steg, Johny Nicolas, Usman Baber, et al.
JACC. Cardiovascular Interventions|June 9, 2022
Polymer-Based Versus Polymer-Free Stents in High Bleeding Risk Patients: Final 2-Year Results From Onyx ONEStephan Windecker, Azeem Latib, Elvin Kedhi, et al.
The New England Journal of Medicine|February 13, 2020
Polymer-based or Polymer-free Stents in Patients at High Bleeding RiskStephan Windecker, Azeem Latib, Elvin Kedhi, et al.
The New England Journal of Medicine|September 27, 2019
Ticagrelor with or without Aspirin in High-Risk Patients after PCIRoxana Mehran, Usman Baber, Samin K Sharma, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Investigation|January 16, 2024
A membrane-associated phosphoswitch in Rad controls adrenergic regulation of cardiac calcium channelsArianne Papa, Pedro J Del Rivero Morfin, Bi-Xing Chen, et al.
Circulation Research|October 22, 2020
Adrenergic Ca<sub>V</sub>1.2 Activation via Rad Phosphorylation Converges at α<sub>1C</sub> I-II LoopArianne Papa, Jared Kushner, Jessica A Hennessey, et al.
Cell Reports. Medicine|March 15, 2023
Engineered cardiac tissue model of restrictive cardiomyopathy for drug discoveryBryan Z Wang, Trevor R Nash, Xiaokan Zhang, et al.
JCI Insight|October 28, 2021
Attenuating persistent sodium current-induced atrial myopathy and fibrillation by preventing mitochondrial oxidative stressUma Mahesh R Avula, Haikel Dridi, Bi-Xing Chen, et al.
Nature Communications|October 17, 2024
Multiple beta cell-independent mechanisms drive hypoglycemia in Timothy syndromeMaiko Matsui, Lauren E Lynch, Isabella Distefano, et al.
Nature Cardiovascular Research|November 25, 2022
Rad regulation of Ca<sub>V</sub>1.2 channels controls cardiac fight-or-flight responseArianne Papa, Sergey I Zakharov, Alexander N Katchman, et al.
American Heart Journal|January 31, 2025
Characterizing high-risk enrollment criteria and impact on clinical outcomes in a large randomized clinical trial: Insights from the TWILIGHT trialPhilippe Gabriel Steg, Johny Nicolas, Usman Baber, et al.
JACC. Cardiovascular Interventions|June 9, 2022
Polymer-Based Versus Polymer-Free Stents in High Bleeding Risk Patients: Final 2-Year Results From Onyx ONEStephan Windecker, Azeem Latib, Elvin Kedhi, et al.
The New England Journal of Medicine|February 13, 2020
Polymer-based or Polymer-free Stents in Patients at High Bleeding RiskStephan Windecker, Azeem Latib, Elvin Kedhi, et al.
The New England Journal of Medicine|September 27, 2019
Ticagrelor with or without Aspirin in High-Risk Patients after PCIRoxana Mehran, Usman Baber, Samin K Sharma, et al.
Pageof 10